News by Tag: Emerging World Pharma
Emerging World Pharma Inc. Strategic Partner African Global Pharma GH Adds Beta-Blocker, Glaten® To Over-The-Counter Lineup
November 12, 2012
African Global Pharma Corp.(AGP) has added the beta-adrenoceptors blocker Glaten® to its over-the-counter line of pharmaceuticals. The medication contains Atenolol and is used for the treatment of hypertension, angina and myocardial infarction.
November 12, 2012
African Global Pharma Corp.(AGP) has added the beta-adrenoceptors blocker Glaten® to its over-the-counter line of pharmaceuticals. The medication contains Atenolol and is used for the treatment of hypertension, angina and myocardial infarction.
Emerging World Pharma Inc. Strategic Partner African Global Pharma Corp. Receives Approval to Produce Anti-diabetic Tablet Gliben
November 8, 2012
African Global Pharma Corp.(AGP) has received full approval from the Food & Drugs Board of Ghana to produce and distribute an anti-diabetic pharmaceutical called Glibenclamide.
November 8, 2012
African Global Pharma Corp.(AGP) has received full approval from the Food & Drugs Board of Ghana to produce and distribute an anti-diabetic pharmaceutical called Glibenclamide.
African Global Pharma (GH) Now Producing First Line Of Over The Counter Analgesic, Paracetamol
November 7, 2012
African Global Pharma Corp. (AGP) continues the roll out of its over-the counter pharmaceuticals producing its line of analgesic pain relievers. AGP is now in the process of manufacturing Paracetamol.
November 7, 2012
African Global Pharma Corp. (AGP) continues the roll out of its over-the counter pharmaceuticals producing its line of analgesic pain relievers. AGP is now in the process of manufacturing Paracetamol.
Emerging World Pharma Inc. Strategic Partner African Global Pharma Corp. Includes Production of Anti-Malarial Pharmaceutical Glod
November 6, 2012
Emerging World Pharma Inc. strategic partner African Global Pharma Corp.(AGP) has initiated the production of the anti-malarial pharmaceutical called Gloderp®.
November 6, 2012
Emerging World Pharma Inc. strategic partner African Global Pharma Corp.(AGP) has initiated the production of the anti-malarial pharmaceutical called Gloderp®.
Emerging World Pharma Inc. Strategic Partner African Global Pharma Corp. Producing Anti-Malarial Pharmaceutical Globartem®
November 5, 2012
Emerging World Pharma Inc. (OTC:EWPI)-Emerging World Pharma Inc. strategic partner African Global Pharma Corp.(AGP) has commenced production of the anti-malarial pharmaceutical Globartem®.
November 5, 2012
Emerging World Pharma Inc. (OTC:EWPI)-Emerging World Pharma Inc. strategic partner African Global Pharma Corp.(AGP) has commenced production of the anti-malarial pharmaceutical Globartem®.
Emerging World Pharma Inc. President Provides Update From Global Pharma Corp. Annual Meeting
November 2, 2012
Emerging World Pharma president attends the annual meeting of the board of directors from the company's strategic partner African Global Pharma Corp.
November 2, 2012
Emerging World Pharma president attends the annual meeting of the board of directors from the company's strategic partner African Global Pharma Corp.